Dariush Mozaffarian MD, DrPH
Dean, Friedman School of Nutrition Science & Policy, Tufts University, Jean Mayer Professor of Nutrition and Medicine, Boston, MA
Dr. Mozaffarian reports consulting fees from Acasti Pharma for serving as the principal investigator of TRILOGY, two phase 3 trials of omega-3 fatty acids to reduce hypertriglyceridemia; and from the Cleveland Clinic Foundation for serving on the Executive Committee of the STRENGTH trial, a large randomized controlled trial of omega-3 fatty acids to reduce cardiovascular events in patients with hypertriglyceridemia. The author also reports ad hoc honoraria or consulting from GOED, DSM, Nutrition Impact, Pollock Communications, Bunge, and Indigo Agriculture; royalties from UpToDate for online medical chapters; scientific advisory board, Omada Health and Elysium Health; and research funding from the National Institutes of Health and the Gates Foundation; all outside the present work.